Jaguar Health, Inc. (JAGX) Preliminary SBS-IF Data Accepted for ACG; Phase 2 Readout H2 2027

Jaguar Health said ACG 2026 accepted an abstract on preliminary open-label data for crofelemer in adult SBS-IF. A randomized Phase 2 in adult Type 1 SBS is ongoing, with results expected early H2 2027; an NDA for MVID is targeted for mid-2027.Material DetailsContext by AI AnalystThis is an early-st…